This is the authors' abstract. We don't add key points for this paper.
In patients with primary breast cancer, the presence of CTCs was an independent predictor of poor disease-free, overall, breast cancer-specific, and distant disease-free survival. Clin Cancer Res; 22(10); 2583-93.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Janni et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: